An appraisal on recent medicinal perspective of curcumin degradant: Dehydrozingerone (DZG).
暂无分享,去创建一个
[1] L. Savegnago,et al. Twice acting antioxidants: synthesis and antioxidant properties of selenium and sulfur-containing zingerone derivatives , 2015 .
[2] G. Rimbach,et al. Thermal stability, antioxidant, and anti-inflammatory activity of curcumin and its degradation product 4-vinyl guaiacol. , 2015, Food & function.
[3] G. Abbas,et al. Saponins: the phytochemical with an emerging potential for curing clinical depression , 2015, Natural product research.
[4] J. O. Lee,et al. Dehydrozingerone exerts beneficial metabolic effects in high-fat diet-induced obese mice viaAMPK activation in skeletal muscle , 2015, Journal of cellular and molecular medicine.
[5] J. Snyder,et al. Eliminating the Heart from the Curcumin Molecule: Monocarbonyl Curcumin Mimics (MACs) , 2014, Molecules.
[6] L. Savegnago,et al. Antidepressant-like activity of dehydrozingerone: Involvement of the serotonergic and noradrenergic systems , 2014, Pharmacology Biochemistry and Behavior.
[7] R. Amarowicz,et al. Protective effects of equimolar mixtures of monomer and dimer of dehydrozingerone with α-tocopherol and/or ascorbyl palmitate during bulk lipid autoxidation. , 2014, Food chemistry.
[8] J. Fajemiroye,et al. Anxiolytic and antidepressant like effects of natural food flavour (E)-methyl isoeugenol. , 2014, Food & function.
[9] P. Zou,et al. Synthesis and biological evaluation of allylated and prenylated mono-carbonyl analogs of curcumin as anti-inflammatory agents. , 2014, European journal of medicinal chemistry.
[10] C. Teng,et al. Synthesis of Analogues of Gingerol and Shogaol, the Active Pungent Principles from the Rhizomes of Zingiber officinale and Evaluation of Their Anti-Platelet Aggregation Effects , 2014, International journal of molecular sciences.
[11] Zai-Qun Liu,et al. Asymmetrical mono-carbonyl ferrocenylidene curcumin and their dihydropyrazole derivatives: Which possesses the highest activity to protect DNA or scavenge radical? , 2014, Medicinal Chemistry Research.
[12] Jung-Chun Liao,et al. Antidepressant-like activity of turmerone in behavioral despair tests in mice , 2013, BMC Complementary and Alternative Medicine.
[13] Xiaokun Li,et al. Evaluation of a curcumin analog as an anti-cancer agent inducing ER stress-mediated apoptosis in non-small cell lung cancer cells , 2013, BMC Cancer.
[14] H. Fu,et al. Design and biological characterization of hybrid compounds of curcumin and thalidomide for multiple myeloma. , 2013, Organic & biomolecular chemistry.
[15] K. Misra,et al. Human papilloma virus 16 e6 protein as a target for curcuminoids, curcumin conjugates and congeners for chemoprevention of oral and cervical cancers , 2013, Interdisciplinary Sciences: Computational Life Sciences.
[16] G. Liang,et al. Discovery and evaluation of piperid-4-one-containing mono-carbonyl analogs of curcumin as anti-inflammatory agents. , 2013, Bioorganic & medicinal chemistry.
[17] J. Ham,et al. Cytotoxicity of Substituted Benzimidazolyl Curcumin Mimics Against Multi-Drug Resistance Cancer Cell , 2013 .
[18] Chengguang Zhao,et al. Promising curcumin-based drug design: mono-carbonyl analogues of curcumin (MACs). , 2013, Current pharmaceutical design.
[19] D. Liao,et al. Synthesis and Anticancer Activity of Mono-Carbonyl Analogues of Curcumin , 2013 .
[20] L. Rao,et al. In vitro antifungal activity of dehydrozingerone and its fungitoxic properties. , 2013, Journal of food science.
[21] T. Sakai,et al. Dehydrozingerone, a structural analogue of curcumin, induces cell-cycle arrest at the G2/M phase and accumulates intracellular ROS in HT-29 human colon cancer cells. , 2012, Journal of natural products.
[22] Liang Shen,et al. Low stability remedies the low bioavailability of curcumin , 2012 .
[23] Liang Shen,et al. The pharmacology of curcumin: is it the degradation products? , 2012, Trends in molecular medicine.
[24] J. Ham,et al. Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity. , 2012, Bioorganic & medicinal chemistry letters.
[25] L. Rao,et al. Structure-function activity of dehydrozingerone and its derivatives as antioxidant and antimicrobial compounds , 2014, Journal of Food Science and Technology.
[26] M. S. Brewer. NATURAL ANTIOXIDANTS: SOURCES, COMPOUNDS, MECHANISMS OF ACTION, AND POTENTIAL APPLICATIONS , 2011 .
[27] P. Paul,et al. Effect of Dehydrozingerone, a half analog of curcumin on dexamethasone-delayed wound healing in albino rats , 2011, Molecular and Cellular Biochemistry.
[28] Zai-Qun Liu,et al. Ferrocenyl-substituted curcumin: can it influence antioxidant ability to protect DNA? , 2011, European journal of medicinal chemistry.
[29] Zai-Qun Liu,et al. Feruloylacetone as the model compound of half-curcumin: synthesis and antioxidant properties. , 2011, European journal of medicinal chemistry.
[30] J. Gut,et al. Design, synthesis and in vitro antimalarial evaluation of triazole-linked chalcone and dienone hybrid compounds. , 2010, Bioorganic & medicinal chemistry.
[31] D. Linseman,et al. Nutraceutical Antioxidants as Novel Neuroprotective Agents , 2010, Molecules.
[32] H. Tokuda,et al. Cancer preventive agents 10. Prenylated dehydrozingerone analogs as potent chemopreventive agents , 2010, Journal of Asian natural products research.
[33] Liang Shen,et al. Insights into the inhibition of xanthine oxidase by curcumin. , 2009, Bioorganic & medicinal chemistry letters.
[34] Jian Xiao,et al. Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents. , 2009, Bioorganic & medicinal chemistry.
[35] D. Suresh,et al. Degradation of bioactive spice compound: curcumin during domestic cooking , 2009 .
[36] S. Kulkarni,et al. Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes , 2009, Pharmacology Biochemistry and Behavior.
[37] J. Elguero,et al. Synthesis and biological evaluation of curcuminoid pyrazoles as new therapeutic agents in inflammatory bowel disease: effect on matrix metalloproteinases. , 2009, Bioorganic & medicinal chemistry.
[38] B. Aggarwal,et al. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. , 2009, Trends in pharmacological sciences.
[39] N. Sreejayan,et al. Inhibitory Effect of Dehydrozingerone on Vascular Smooth Muscle Cell Function , 2007, Journal of cardiovascular pharmacology.
[40] Robert A Newman,et al. Bioavailability of curcumin: problems and promises. , 2007, Molecular pharmaceutics.
[41] S. Manjula,et al. Free radical scavenging and radioprotective activity of dehydrozingerone against whole body gamma irradiation in Swiss albino mice. , 2007, Chemico-biological interactions.
[42] M. Hung,et al. Antitumor agents. 258. Syntheses and evaluation of dietary antioxidant--taxoid conjugates as novel cytotoxic agents. , 2007, Bioorganic & medicinal chemistry letters.
[43] K. Lee,et al. Anti-tumor agents 255: novel glycyrrhetinic acid-dehydrozingerone conjugates as cytotoxic agents. , 2007, Bioorganic & medicinal chemistry.
[44] G. Litwinienko,et al. DSC study of linolenic acid autoxidation inhibited by BHT, dehydrozingerone and olivetol , 2007 .
[45] E. Barreiro,et al. Molecular hybridization: a useful tool in the design of new drug prototypes. , 2007, Current medicinal chemistry.
[46] M. Másson,et al. Studies on curcumin and curcuminoids XXXI. Symmetric and asymmetric curcuminoids: stability, activity and complexation with cyclodextrin. , 2007, International journal of pharmaceutics.
[47] K. Lee,et al. Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents. , 2006, Journal of natural products.
[48] Eun Kyoung Ryu,et al. Curcumin and dehydrozingerone derivatives: synthesis, radiolabeling, and evaluation for beta-amyloid plaque imaging. , 2006, Journal of medicinal chemistry.
[49] E. Bobrovnikova-Marjon,et al. Activation of NFκB is inhibited by curcumin and related enones , 2006 .
[50] G. Grogan. Emergent mechanistic diversity of enzyme-catalysed β-diketone cleavage , 2005 .
[51] C. Teng,et al. Isolation of a Natural Antioxidant, Dehydrozingerone from Zingiber officinale and Synthesis of Its Analogues for Recognition of Effective Antioxidant and Antityrosinase Agents , 2005, Archives of pharmacal research.
[52] T. Tanahashi,et al. Quantitative structure-activity relationship analyses of antioxidant and free radical scavenging activities for hydroxybenzalacetones. , 2004, Bioorganic & medicinal chemistry letters.
[53] Lisa St John-Williams,et al. Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto reductases. , 2004, Chemico-biological interactions.
[54] Darrick S. H. L. Kim,et al. Side-chain length is important for shogaols in protecting neuronal cells from beta-amyloid insult. , 2004, Bioorganic & medicinal chemistry letters.
[55] Y. K. Kim,et al. Chemical Hypoxia-Induced Cell Death in Human Glioma Cells: Role of Reactive Oxygen Species, ATP Depletion, Mitochondrial Damage and Ca2+ , 2003, Neurochemical Research.
[56] M. Rao,et al. Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates , 1994, Molecular and Cellular Biochemistry.
[57] David J Newman,et al. Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.
[58] D. W. Ribbons,et al. Acetylacetone-cleaving enzyme Dke1: a novel C-C-bond-cleaving enzyme from Acinetobacter johnsonii. , 2003, The Biochemical journal.
[59] S. B. Rao,et al. Novel Method Of Synthesis Of Curcuminoids And Derivative Of Ibuprofen As Potent Antiinflammatory Agent , 2002 .
[60] B. Khambay,et al. Insect growth inhibition, antifeedant and antifungal activity of compounds isolated/derived from Zingiber officinale Roscoe (ginger) rhizomes. , 2001, Pest management science.
[61] M. Nair,et al. Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. , 2000, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[62] Matthew S. Mitchell,et al. Isolation of Curcumin from Turmeric , 2000 .
[63] H. Nishino,et al. Structure-activity relationship in potentially anti-tumor promoting benzalacetone derivatives, as assayed by the epstein-barr virus early antigen activation. , 2000, Mutation research.
[64] D J Newman,et al. The influence of natural products upon drug discovery. , 2000, Natural product reports.
[65] S. Jovanovic,et al. H-Atom Transfer Is A Preferred Antioxidant Mechanism of Curcumin , 1999 .
[66] K. Priyadarsini,et al. Properties of phenoxyl radical of dehydrozingerone, a probable antioxidant , 1999 .
[67] M. Rao,et al. In vitro and in vivo effects of phenolic antioxidants against cisplatin-induced nephrotoxicity. , 1999, Journal of biochemistry.
[68] G. Samuelsson. Drugs of natural origin : a textbook of pharmacognosy , 1999 .
[69] H. Nishino,et al. Inhibitory effects of dehydrozingerone and related compounds on 12-O-tetradecanoylphorbol-13-acetate induced Epstein-Barr virus early antigen activation. , 1998, Cancer letters.
[70] R. Sangwan,et al. Plant‐derived products as antimutagens , 1998 .
[71] S. B. Rao,et al. Synthesis And Pharmacological Activity Of Some Mannich Bases Of Dehydrozingerone , 1998 .
[72] K. Priyadarsini,et al. Physico-chemical properties and antioxidant activities of methoxy phenols. , 1998, Free radical biology & medicine.
[73] Jen-kun Lin,et al. Stability of curcumin in buffer solutions and characterization of its degradation products. , 1997, Journal of pharmaceutical and biomedical analysis.
[74] H. Timmerman,et al. 1,5-Diphenyl-1,4-pentadiene-3-ones and cyclic analogues as antioxidative agents. Synthesis and structure-activity relationship , 1997 .
[75] Y. Saito,et al. Antimutagenic effects of dehydrozingerone and its analogs on UV-induced mutagenesis in Escherichia coli. , 1997, Mutation research.
[76] D J Newman,et al. Natural products in drug discovery and development. , 1997, Journal of natural products.
[77] K. N. Rajasekharan,et al. Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. , 1996, Mutation research.
[78] G. Kuttan,et al. Anti-tumour and free radical scavenging activity of synthetic curcuminoids , 1996 .
[79] G. Kuttan,et al. Anti-tumour and antioxidant activity of natural curcuminoids. , 1995, Cancer letters.
[80] T. Devasagayam,et al. Diminution of singlet oxygen-induced DNA damage by curcumin and related antioxidants. , 1994, Mutation research.
[81] Bin-Nan Wu,et al. A new β-adrenoceptor blocking agent derived from dehydrozingerone , 1994 .
[82] M. Rao,et al. Dehydrozingerone and isoeugenol as inhibitors of lipid peroxidation and as free radical scavengers. , 1993, Biochemical pharmacology.
[83] G. Elias,et al. Synthesis and anti-inflammatory activity of substituted (E)-4-phenyl-3-buten-2-ones , 1988 .
[84] G. Vidari,et al. Dehydrozingerone from Aframomum giganteum , 1976 .
[85] Mi-Kyung Sung,et al. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease , 2022 .